Bp Wealth Management »

Esperion Therapeutics shares owned by Bp Wealth Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Bp Wealth Management from 13F filings

Historical chart of Bp Wealth Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Bp Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Bp Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $181k 61k 2.99

More positions owned by Bp Wealth Management

Applovin Corp Class A (APP)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Core S&p 500 Etf Etf (IVV)
Spdr S&p500 Etf Trust Trust Un Etf (SPY)
iShares Short Treasury Bond Etf (SHV)
10x Genomics Inc Cl A (TXG)
Ishares Tr Rus 1000 Grw Etf Etf (IWF)
Vanguard Index Funds S&p 500 E Etf (VOO)
Amazon (AMZN)
Broadcom (AVGO)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Ishares Tr Msci Usa Qlt Fct Etf (QUAL)
iShares Core S&P Total U.S. St Etf (ITOT)

View all positions for Bp Wealth Management

Top funds holding Esperion Therapeutics

Daniel D. Thurber
Vanguard Group
Bellevue Group
Meditor
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Tang Capital Management
D. E. Shaw & Co
Walleye Trading
GSA Capital Partners
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Goldman Sachs Group

View all funds holding Esperion Therapeutics